Next Article in Journal
Integrin α10, a Novel Therapeutic Target in Glioblastoma, Regulates Cell Migration, Proliferation, and Survival
Next Article in Special Issue
Impact of Extrinsic and Intrinsic Hypoxia on Catecholamine Biosynthesis in Absence or Presence of Hif2α in Pheochromocytoma Cells
Previous Article in Journal
Deletions of Chromosome 7q Affect Nuclear Organization and HLXB9Gene Expression in Hematological Disorders
Previous Article in Special Issue
FGF21 Levels in Pheochromocytoma/Functional Paraganglioma
Article Menu
Issue 4 (April) cover image

Export Article

Open AccessArticle

Chromogranin A in the Laboratory Diagnosis of Pheochromocytoma and Paraganglioma

1
Institute of Endocrinology, Národní 8, 116 94 Prague, Czech Republic
2
Department of Nuclear Medicine and Endocrinology, Motol Teaching Hospital and Second Faculty of Medicine, Charles University, V Úvalu 84, 15006 Prague 5, Czech Republic
3
Urology Clinic, V Pražské bráně 74, 26601 Beroun, Czech Republic
4
1st Department of Surgery-Department of Abdominal, Thoracic Surgery and Traumatology, First Faculty of Medicine, Charles University and General University Hospital, U Nemocnice 2, 12808 Prague 2, Czech Republic
5
Department of Urology, First Faculty of Medicine, Charles University and General University Hospital, Ke Karlovu 4, 12808 Prague 2, Czech Republic
6
Institute of Pathology, First Faculty of Medicine, Charles University in Prague and General University Hospital, Studničkova 2, 12800 Prague 2, Czech Republic
7
Center for Hypertension, 3rd Medical Department-Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University and General University Hospital, U Nemocnice 1, 12808 Prague 2, Czech Republic
*
Author to whom correspondence should be addressed.
Cancers 2019, 11(4), 586; https://doi.org/10.3390/cancers11040586
Received: 17 March 2019 / Revised: 15 April 2019 / Accepted: 17 April 2019 / Published: 25 April 2019
(This article belongs to the Special Issue Pheochromocytoma (PHEO) and Paraganglioma (PGL))
  |  
PDF [1003 KB, uploaded 26 April 2019]
  |     |  

Abstract

This work discusses the clinical performance of chromogranin A (CGA), a commonly measured marker in neuroendocrine neoplasms, for the diagnosis of pheochromocytoma/paraganglioma (PPGL). Plasma CGA (cut-off value 150 µg/L) was determined by an immunoradiometric assay. Free metanephrine (cut-off value 100 ng/L) and normetanephrine (cut-off value 170 ng/L) were determined by radioimmunoassay. Blood samples were collected from PPGL patients preoperatively, one week, six months, one year and two years after adrenal gland surgery. The control patients not diagnosed with PPGL suffered from adrenal problems or from MEN2 and thyroid carcinoma. The clinical sensitivity in the PPGL group of patients (n = 71) based on CGA is 90% and is below the clinical sensitivity determined by metanephrines (97%). The clinical specificity based on all plasma CGA values after surgery (n = 98) is 99% and is the same for metanephrines assays. The clinical specificity of CGA in the control group (n = 85) was 92% or 99% using metanephrines tests. We can conclude that plasma CGA can serve as an appropriate complement to metanephrines assays in laboratory diagnosis of PPGL patients. CGA is elevated in PPGLs, as well as in other neuroendocrine or non-neuroendocrine neoplasia and under clinical conditions increasing adrenergic activity. View Full-Text
Keywords: chromogranin A; metanephrines; pheochromocytoma; paraganglioma chromogranin A; metanephrines; pheochromocytoma; paraganglioma
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Bílek, R.; Vlček, P.; Šafařík, L.; Michalský, D.; Novák, K.; Dušková, J.; Václavíková, E.; Widimský, J., Jr.; Zelinka, T. Chromogranin A in the Laboratory Diagnosis of Pheochromocytoma and Paraganglioma. Cancers 2019, 11, 586.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top